會員登入
註冊
Synmosa Biopharma Moves to Acquire up to 30% of Genovate Bio at a 30% Premium
2025-09-16 / 新聞中心
SynmosaBiopharma (4114.TWO)announcedthatitsBoardhasapprovedaplantoacquire15%–30%ofGenovateBio (4130.TWO)sharesthroughapublictenderofferatNT$24pershare—a30%premiumoverGenovate'slatestcl...
